Literature DB >> 23101195

Rapid desensitization with temozolomide in patients with delayed maculopapular rash.

A Alonso-Llamazares1, A Vega-Castro, J M Beitia-Mazuecos, B Mateo-Borrega, R Cardenas-Contreras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23101195

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN： 1018-9068            Impact factor:   4.333


× No keyword cloud information.
  5 in total

Review 1.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

2.  Two cases of cutaneous drug eruption associated with temozolomide therapy for glioblastoma.

Authors:  E Deluche; S Leobon; F Touraine; P Clavère
Journal:  Curr Oncol       Date:  2014-12       Impact factor: 3.677

3.  Toxic epidermal necrolysis in polymedicated patient treated with radiotherapy.

Authors:  Remedios Pérez-Calderón; M Angeles Gonzalo-Garijo; Silvia Corrales-Vargas; Gloria Jiménez-Ferrera; Isabel Rodríguez-Nevado; Mario Díaz-Delgado
Journal:  Allergy Asthma Immunol Res       Date:  2014-09-19       Impact factor: 5.764

4.  Cutaneous adverse drug reaction associated with oral temozolomide presenting as dermal and subcutaneous plaques and nodules.

Authors:  Pooja Virmani; Esther Chung; Alissa A Thomas; Ingo K Mellinghoff; Michael A Marchetti
Journal:  JAAD Case Rep       Date:  2015-07-29

5.  Use of Rapid Drug Desensitization in Delayed Hypersensitivity Reactions to Chemotherapy and Monoclonal Antibodies.

Authors:  Arantza Vega; M Isabel Peña; Inés Torrado
Journal:  Front Allergy       Date:  2022-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.